Request Sample Inquiry
Oligonucleotide Synthesis Market

Oligonucleotide Synthesis Market

Oligonucleotide Synthesis Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

132

Base Year:

2022

Date

Jan - 2024

Format:

PDF XLS PPT

Report Code:

VMR-2366

Segments Covered
  • By Product By Product Synthesized Oligonucleotides, Oligonucleotide-based Drugs, Reagents, Equipment
  • By Application By Application Therapeutic Applications, Diagnostic Applications, Research Applications
  • By End User By End User Hospitals, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, CROs and CMOs, Academic Research Institutes
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 7.3 Billion
Revenue 2030Revenue 2030: USD 24.1 Billion
Revenue CAGRRevenue CAGR (2023 - 2030): 16.1%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Oligonucleotide Synthesis Market - Segment Analysis
    1. Overview
    2. Global Oligonucleotide Synthesis Market, 2016 - 2028 (USD Million)
    3. Global Oligonucleotide Synthesis Market - by Product
      1. By Synthesized Oligonucleotides
      2. By Oligonucleotide-based Drugs
      3. By Reagents
      4. By Equipment
    4. Global Oligonucleotide Synthesis Market - by Application
      1. By Therapeutic Applications
      2. By Diagnostic Applications
      3. By Research Applications
    5. Global Oligonucleotide Synthesis Market - by End User
      1. By Hospitals
      2. By Pharmaceutical & Biotechnology Companies
      3. By Diagnostic Laboratories
      4. By CROs and CMOs
      5. By Academic Research Institutes
    6. Global Oligonucleotide Synthesis Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    7. Market comparative analysis
  4. North America Oligonucleotide Synthesis Market - Segment Analysis
    1. Overview
    2. North America Oligonucleotide Synthesis Market, 2016 - 2028 (USD Million)
    3. North America Oligonucleotide Synthesis Market, by Product
      1. By Synthesized Oligonucleotides
      2. By Oligonucleotide-based Drugs
      3. By Reagents
      4. By Equipment
    4. North America Oligonucleotide Synthesis Market, by Application
      1. By Therapeutic Applications
      2. By Diagnostic Applications
      3. By Research Applications
    5. North America Oligonucleotide Synthesis Market, by End User
      1. By Hospitals
      2. By Pharmaceutical & Biotechnology Companies
      3. By Diagnostic Laboratories
      4. By CROs and CMOs
      5. By Academic Research Institutes
    6. North America Oligonucleotide Synthesis Market, by Country
      1. U.S.
        1. U.S. Oligonucleotide Synthesis Market, By Product
          1. By Synthesized Oligonucleotides
          2. By Oligonucleotide-based Drugs
          3. By Reagents
          4. By Equipment
        2. U.S. Oligonucleotide Synthesis Market, By Application
          1. By Therapeutic Applications
          2. By Diagnostic Applications
          3. By Research Applications
        3. U.S. Oligonucleotide Synthesis Market, By End User
          1. By Hospitals
          2. By Pharmaceutical & Biotechnology Companies
          3. By Diagnostic Laboratories
          4. By CROs and CMOs
          5. By Academic Research Institutes
      2. Canada
        1. Canada Oligonucleotide Synthesis Market, By Product
          1. By Synthesized Oligonucleotides
          2. By Oligonucleotide-based Drugs
          3. By Reagents
          4. By Equipment
        2. Canada Oligonucleotide Synthesis Market, By Application
          1. By Therapeutic Applications
          2. By Diagnostic Applications
          3. By Research Applications
        3. Canada Oligonucleotide Synthesis Market, By End User
          1. By Hospitals
          2. By Pharmaceutical & Biotechnology Companies
          3. By Diagnostic Laboratories
          4. By CROs and CMOs
          5. By Academic Research Institutes
      3. Mexico
        1. Mexico Oligonucleotide Synthesis Market, By Product
          1. By Synthesized Oligonucleotides
          2. By Oligonucleotide-based Drugs
          3. By Reagents
          4. By Equipment
        2. Mexico Oligonucleotide Synthesis Market, By Application
          1. By Therapeutic Applications
          2. By Diagnostic Applications
          3. By Research Applications
        3. Mexico Oligonucleotide Synthesis Market, By End User
          1. By Hospitals
          2. By Pharmaceutical & Biotechnology Companies
          3. By Diagnostic Laboratories
          4. By CROs and CMOs
          5. By Academic Research Institutes
  5. Europe Oligonucleotide Synthesis Market - Segment Analysis
    1. Overview
    2. Europe Oligonucleotide Synthesis Market, 2016 - 2028 (USD Million)
    3. Europe Oligonucleotide Synthesis Market, by Product
      1. By Synthesized Oligonucleotides
      2. By Oligonucleotide-based Drugs
      3. By Reagents
      4. By Equipment
    4. Europe Oligonucleotide Synthesis Market, by Application
      1. By Therapeutic Applications
      2. By Diagnostic Applications
      3. By Research Applications
    5. Europe Oligonucleotide Synthesis Market, by End User
      1. By Hospitals
      2. By Pharmaceutical & Biotechnology Companies
      3. By Diagnostic Laboratories
      4. By CROs and CMOs
      5. By Academic Research Institutes
    6. Europe Oligonucleotide Synthesis Market, by Country
      1. Germany
        1. Germany Oligonucleotide Synthesis Market, By Product
          1. By Synthesized Oligonucleotides
          2. By Oligonucleotide-based Drugs
          3. By Reagents
          4. By Equipment
        2. Germany Oligonucleotide Synthesis Market, By Application
          1. By Therapeutic Applications
          2. By Diagnostic Applications
          3. By Research Applications
        3. Germany Oligonucleotide Synthesis Market, By End User
          1. By Hospitals
          2. By Pharmaceutical & Biotechnology Companies
          3. By Diagnostic Laboratories
          4. By CROs and CMOs
          5. By Academic Research Institutes
      2. UK
        1. UK Market, By Product
          1. By Synthesized Oligonucleotides
          2. By Oligonucleotide-based Drugs
          3. By Reagents
          4. By Equipment
        2. UK Market, By Application
          1. By Therapeutic Applications
          2. By Diagnostic Applications
          3. By Research Applications
        3. UK Market, By End User
          1. By Hospitals
          2. By Pharmaceutical & Biotechnology Companies
          3. By Diagnostic Laboratories
          4. By CROs and CMOs
          5. By Academic Research Institutes
      3. France
        1. France Oligonucleotide Synthesis Market, By Product
          1. By Synthesized Oligonucleotides
          2. By Oligonucleotide-based Drugs
          3. By Reagents
          4. By Equipment
        2. France Oligonucleotide Synthesis Market, By Application
          1. By Therapeutic Applications
          2. By Diagnostic Applications
          3. By Research Applications
        3. France Oligonucleotide Synthesis Market, By End User
          1. By Hospitals
          2. By Pharmaceutical & Biotechnology Companies
          3. By Diagnostic Laboratories
          4. By CROs and CMOs
          5. By Academic Research Institutes
      4. Spain
        1. Spain Oligonucleotide Synthesis Market, By Product
          1. By Synthesized Oligonucleotides
          2. By Oligonucleotide-based Drugs
          3. By Reagents
          4. By Equipment
        2. Spain Oligonucleotide Synthesis Market, By Application
          1. By Therapeutic Applications
          2. By Diagnostic Applications
          3. By Research Applications
        3. Spain Oligonucleotide Synthesis Market, By End User
          1. By Hospitals
          2. By Pharmaceutical & Biotechnology Companies
          3. By Diagnostic Laboratories
          4. By CROs and CMOs
          5. By Academic Research Institutes
      5. Italy
        1. Italy Oligonucleotide Synthesis Market, By Product
          1. By Synthesized Oligonucleotides
          2. By Oligonucleotide-based Drugs
          3. By Reagents
          4. By Equipment
        2. Italy Oligonucleotide Synthesis Market, By Application
          1. By Therapeutic Applications
          2. By Diagnostic Applications
          3. By Research Applications
        3. Italy Oligonucleotide Synthesis Market, By End User
          1. By Hospitals
          2. By Pharmaceutical & Biotechnology Companies
          3. By Diagnostic Laboratories
          4. By CROs and CMOs
          5. By Academic Research Institutes
      6. BENELUX
        1. BENELUX Oligonucleotide Synthesis Market, By Product
          1. By Synthesized Oligonucleotides
          2. By Oligonucleotide-based Drugs
          3. By Reagents
          4. By Equipment
        2. BENELUX Oligonucleotide Synthesis Market, By Application
          1. By Therapeutic Applications
          2. By Diagnostic Applications
          3. By Research Applications
        3. BENELUX Oligonucleotide Synthesis Market, By End User
          1. By Hospitals
          2. By Pharmaceutical & Biotechnology Companies
          3. By Diagnostic Laboratories
          4. By CROs and CMOs
          5. By Academic Research Institutes
      7. Rest of Europe
        1. Rest Of Europe Oligonucleotide Synthesis Market, By Product
          1. By Synthesized Oligonucleotides
          2. By Oligonucleotide-based Drugs
          3. By Reagents
          4. By Equipment
        2. Rest Of Europe Oligonucleotide Synthesis Market, By Application
          1. By Therapeutic Applications
          2. By Diagnostic Applications
          3. By Research Applications
        3. Rest Of Europe Oligonucleotide Synthesis Market, By End User
          1. By Hospitals
          2. By Pharmaceutical & Biotechnology Companies
          3. By Diagnostic Laboratories
          4. By CROs and CMOs
          5. By Academic Research Institutes
  6. Asia Pacific Oligonucleotide Synthesis Market - Segment Analysis
    1. Overview
    2. Asia Pacific Oligonucleotide Synthesis Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Oligonucleotide Synthesis Market, by Product
      1. By Synthesized Oligonucleotides
      2. By Oligonucleotide-based Drugs
      3. By Reagents
      4. By Equipment
    4. Asia Pacific Oligonucleotide Synthesis Market, by Application
      1. By Therapeutic Applications
      2. By Diagnostic Applications
      3. By Research Applications
    5. Asia Pacific Oligonucleotide Synthesis Market, by End User
      1. By Hospitals
      2. By Pharmaceutical & Biotechnology Companies
      3. By Diagnostic Laboratories
      4. By CROs and CMOs
      5. By Academic Research Institutes
    6. Asia Pacific Oligonucleotide Synthesis Market, by Country
      1. China
        1. China Oligonucleotide Synthesis Market, By Product
          1. By Synthesized Oligonucleotides
          2. By Oligonucleotide-based Drugs
          3. By Reagents
          4. By Equipment
        2. China Oligonucleotide Synthesis Market, By Application
          1. By Therapeutic Applications
          2. By Diagnostic Applications
          3. By Research Applications
        3. China Oligonucleotide Synthesis Market, By End User
          1. By Hospitals
          2. By Pharmaceutical & Biotechnology Companies
          3. By Diagnostic Laboratories
          4. By CROs and CMOs
          5. By Academic Research Institutes
      2. Japan
        1. Japan Oligonucleotide Synthesis Market, By Product
          1. By Synthesized Oligonucleotides
          2. By Oligonucleotide-based Drugs
          3. By Reagents
          4. By Equipment
        2. Japan Oligonucleotide Synthesis Market, By Application
          1. By Therapeutic Applications
          2. By Diagnostic Applications
          3. By Research Applications
        3. Japan Oligonucleotide Synthesis Market, By End User
          1. By Hospitals
          2. By Pharmaceutical & Biotechnology Companies
          3. By Diagnostic Laboratories
          4. By CROs and CMOs
          5. By Academic Research Institutes
      3. India
        1. India Oligonucleotide Synthesis Market, By Product
          1. By Synthesized Oligonucleotides
          2. By Oligonucleotide-based Drugs
          3. By Reagents
          4. By Equipment
        2. India Oligonucleotide Synthesis Market, By Application
          1. By Therapeutic Applications
          2. By Diagnostic Applications
          3. By Research Applications
        3. India Oligonucleotide Synthesis Market, By End User
          1. By Hospitals
          2. By Pharmaceutical & Biotechnology Companies
          3. By Diagnostic Laboratories
          4. By CROs and CMOs
          5. By Academic Research Institutes
      4. South Korea
        1. South Korea Oligonucleotide Synthesis Market, By Product
          1. By Synthesized Oligonucleotides
          2. By Oligonucleotide-based Drugs
          3. By Reagents
          4. By Equipment
        2. South Korea Oligonucleotide Synthesis Market, By Application
          1. By Therapeutic Applications
          2. By Diagnostic Applications
          3. By Research Applications
        3. South Korea Oligonucleotide Synthesis Market, By End User
          1. By Hospitals
          2. By Pharmaceutical & Biotechnology Companies
          3. By Diagnostic Laboratories
          4. By CROs and CMOs
          5. By Academic Research Institutes
      5. South East Asia
        1. South East Asia Oligonucleotide Synthesis Market, By Product
          1. By Synthesized Oligonucleotides
          2. By Oligonucleotide-based Drugs
          3. By Reagents
          4. By Equipment
        2. South East Asia Oligonucleotide Synthesis Market, By Application
          1. By Therapeutic Applications
          2. By Diagnostic Applications
          3. By Research Applications
        3. South East Asia Oligonucleotide Synthesis Market, By End User
          1. By Hospitals
          2. By Pharmaceutical & Biotechnology Companies
          3. By Diagnostic Laboratories
          4. By CROs and CMOs
          5. By Academic Research Institutes
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Oligonucleotide Synthesis Market, By Product
          1. By Synthesized Oligonucleotides
          2. By Oligonucleotide-based Drugs
          3. By Reagents
          4. By Equipment
        2. Rest of Asia Pacific Oligonucleotide Synthesis Market, By Application
          1. By Therapeutic Applications
          2. By Diagnostic Applications
          3. By Research Applications
        3. Rest of Asia Pacific Oligonucleotide Synthesis Market, By End User
          1. By Hospitals
          2. By Pharmaceutical & Biotechnology Companies
          3. By Diagnostic Laboratories
          4. By CROs and CMOs
          5. By Academic Research Institutes
  7. Latin America Oligonucleotide Synthesis Market - Segment Analysis
    1. Overview
    2. Latin America Oligonucleotide Synthesis Market, 2016 - 2028 (USD Million)
    3. Latin America Oligonucleotide Synthesis Market, by Product
      1. By Synthesized Oligonucleotides
      2. By Oligonucleotide-based Drugs
      3. By Reagents
      4. By Equipment
    4. Latin America Oligonucleotide Synthesis Market, by Application
      1. By Therapeutic Applications
      2. By Diagnostic Applications
      3. By Research Applications
    5. Latin America Oligonucleotide Synthesis Market, by End User
      1. By Hospitals
      2. By Pharmaceutical & Biotechnology Companies
      3. By Diagnostic Laboratories
      4. By CROs and CMOs
      5. By Academic Research Institutes
    6. Latin America Oligonucleotide Synthesis Market, by Country
      1. Brazil
        1. Brazil Oligonucleotide Synthesis Market, By Product
          1. By Synthesized Oligonucleotides
          2. By Oligonucleotide-based Drugs
          3. By Reagents
          4. By Equipment
        2. Brazil Oligonucleotide Synthesis Market, By Application
          1. By Therapeutic Applications
          2. By Diagnostic Applications
          3. By Research Applications
        3. Brazil Oligonucleotide Synthesis Market, By End User
          1. By Hospitals
          2. By Pharmaceutical & Biotechnology Companies
          3. By Diagnostic Laboratories
          4. By CROs and CMOs
          5. By Academic Research Institutes
      2. Argentina
        1. Argentina Oligonucleotide Synthesis Market, By Product
          1. By Synthesized Oligonucleotides
          2. By Oligonucleotide-based Drugs
          3. By Reagents
          4. By Equipment
        2. Argentina Oligonucleotide Synthesis Market, By Application
          1. By Therapeutic Applications
          2. By Diagnostic Applications
          3. By Research Applications
        3. Argentina Oligonucleotide Synthesis Market, By End User
          1. By Hospitals
          2. By Pharmaceutical & Biotechnology Companies
          3. By Diagnostic Laboratories
          4. By CROs and CMOs
          5. By Academic Research Institutes
      3. Rest of Latin America
        1. Rest of Latin America Oligonucleotide Synthesis Market, By Product
          1. By Synthesized Oligonucleotides
          2. By Oligonucleotide-based Drugs
          3. By Reagents
          4. By Equipment
        2. Rest of Latin America Oligonucleotide Synthesis Market, By Application
          1. By Therapeutic Applications
          2. By Diagnostic Applications
          3. By Research Applications
        3. Rest of Latin America Oligonucleotide Synthesis Market, By End User
          1. By Hospitals
          2. By Pharmaceutical & Biotechnology Companies
          3. By Diagnostic Laboratories
          4. By CROs and CMOs
          5. By Academic Research Institutes
  8. Middle East & Africa Oligonucleotide Synthesis Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Oligonucleotide Synthesis Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Oligonucleotide Synthesis Market, by Product
      1. By Synthesized Oligonucleotides
      2. By Oligonucleotide-based Drugs
      3. By Reagents
      4. By Equipment
    4. Middle East & Africa Oligonucleotide Synthesis Market, by Application
      1. By Therapeutic Applications
      2. By Diagnostic Applications
      3. By Research Applications
    5. Middle East & Africa Oligonucleotide Synthesis Market, by End User
      1. By Hospitals
      2. By Pharmaceutical & Biotechnology Companies
      3. By Diagnostic Laboratories
      4. By CROs and CMOs
      5. By Academic Research Institutes
    6. Middle East & Africa Oligonucleotide Synthesis Market, by Country
      1. GCC Countries
        1. GCC Countries Oligonucleotide Synthesis Market, By Product
          1. By Synthesized Oligonucleotides
          2. By Oligonucleotide-based Drugs
          3. By Reagents
          4. By Equipment
        2. GCC Countries Oligonucleotide Synthesis Market, By Application
          1. By Therapeutic Applications
          2. By Diagnostic Applications
          3. By Research Applications
        3. GCC Countries Oligonucleotide Synthesis Market, By End User
          1. By Hospitals
          2. By Pharmaceutical & Biotechnology Companies
          3. By Diagnostic Laboratories
          4. By CROs and CMOs
          5. By Academic Research Institutes
      2. South Africa
        1. South Africa Oligonucleotide Synthesis Market, By Product
          1. By Synthesized Oligonucleotides
          2. By Oligonucleotide-based Drugs
          3. By Reagents
          4. By Equipment
        2. South Africa Oligonucleotide Synthesis Market, By Application
          1. By Therapeutic Applications
          2. By Diagnostic Applications
          3. By Research Applications
        3. South Africa Oligonucleotide Synthesis Market, By End User
          1. By Hospitals
          2. By Pharmaceutical & Biotechnology Companies
          3. By Diagnostic Laboratories
          4. By CROs and CMOs
          5. By Academic Research Institutes
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Oligonucleotide Synthesis Market, By Product
          1. By Synthesized Oligonucleotides
          2. By Oligonucleotide-based Drugs
          3. By Reagents
          4. By Equipment
        2. Rest of Middle East & Africa Oligonucleotide Synthesis Market, By Application
          1. By Therapeutic Applications
          2. By Diagnostic Applications
          3. By Research Applications
        3. Rest of Middle East & Africa Oligonucleotide Synthesis Market, By End User
          1. By Hospitals
          2. By Pharmaceutical & Biotechnology Companies
          3. By Diagnostic Laboratories
          4. By CROs and CMOs
          5. By Academic Research Institutes
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Agilent Technologies Inc. (U.S.)
    2. Atdbio Ltd. (UK)
    3. LGC Limited (UK)
    4. Bio-Synthesis Inc. (U.S.)
    5. Eurofins Genomics (Luxembourg)
    6. Kaneka Eurogentec S.A. (Belgium)
    7. General Electric (U.S.)
    8. Genscript (U.S.)
    9. Ajinomoto Co. Inc. (Japan)
    10. Danaher Corp. (U.S.)
    11. Merck Kgaa (Germany)
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
FAQ
Frequently Asked Question
  • The global Oligonucleotide Synthesis valued at USD 7.3 Billion in 2022 and is expected to reach USD 24.1 Billion in 2030 growing at a CAGR of 16.1%.

  • The prominent players in the market are Agilent Technologies Inc. (U.S.), Atdbio Ltd. (UK), LGC Limited (UK), Bio-Synthesis Inc. (U.S.), Eurofins Genomics (Luxembourg), Kaneka Eurogentec S.A. (Belgium), General Electric (U.S.), Genscript (U.S.), Ajinomoto Co. Inc. (Japan), Danaher Corp. (U.S.), Merck Kgaa (Germany).

  • The market is project to grow at a CAGR of 16.1% between 2023 and 2030.

  • The driving factors of the Oligonucleotide Synthesis include

  • North America was the leading regional segment of the Oligonucleotide Synthesis in 2022.